Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction

Researchers from the Cleveland Clinic and IBM Research have developed a quantum machine learning framework to predict which tumor gene mutations generate immunogenic neoantigens—abnormal cell-surface proteins that trigger a therapeutic T-cell immune response. Published in Science Advances under the title “Quantum convolutional HLA immunogenic peptide prediction (Q-CHIPP): Next-generation neoantigen prediction with quantum neural network,” the […]

The post Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction appeared first on Quantum Computing Report.